SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Glenn Petersen who wrote (21501)10/25/2022 8:05:21 AM
From: Sam2 Recommendations

Recommended By
Glenn Petersen
oldbeachlvr

  Read Replies (4) of 22868
 
Here is MedPage Today's story on that ivermectin study.

Ivermectin: Still on a Losing Streak as COVID-19 Treatment — ACTIV-6 trial shows no time-to-recovery benefit with anti-parasitic in mild-to-moderate disease
by Ed Susman, Contributing Writer, MedPage Today

October 22, 2022

medpagetoday.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News